Results 231 to 240 of about 5,027,651 (300)

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development

Arthritis Care &Research, EarlyView.
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg, Izzy Hartel, Lisa R. Sammaritano, Anca Askanase, Bonnie L. Bermas, Maria Dall'Era, Alí Duarte‐García, Victoria P. Werth, Brad Rovin, Reem A. Mustafa, Amy S. Turner, Bené Williams, Brian L. Ung, Hiya Bhavsar, Monique C. Gore‐Massy, Nahirannette Pulido, Natacha Guerrero, Natalie M. Smith, Wambui Machua, Linda T. Hiraki, Mary Beth Son   +20 more
wiley   +1 more source

Explorative industrial internet promotes open green innovation in manufacturing enterprises. [PDF]

Sci Rep
Hu R, Guoyong M, Abbas A, Wattoo MU.
europepmc   +1 more source

Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout

Arthritis Care &Research, EarlyView.
Objective Body mass index (BMI), glomerular filtration rate (GFR), and pretreatment urate levels have been reported to influence the urate‐lowering response to allopurinol. We investigated whether the fractional excretion of uric acid (FEUA) also modulates this response and relates to oxypurinol concentrations.
Pascal Richette, Anouk Walter‐Petrich, Quang Dinh Nguyen, Matthieu Resche‐Rigon, Quang Huy Dinh Nguyen, Minh Duc Do, Thao Phuong Mai, Tuan Duc Nguyen, Fernando Perez‐Ruiz, Emmanuel Letavernier, Tristan Pascart, Augustin Latourte, Hang Korng Ea, Thomas Bardin   +13 more
wiley   +1 more source

Reporting Horizon Scanning Studies: Prototype Development Study.

J Med Internet Res
Garcia Gonzalez-Moral S, Fairweather M, Khan S, Fairbairn R, Norman G.   +4 more
europepmc   +1 more source

The governance of surgical innovation in the UK National Health Service. [PDF]

Br J Surg
Blazeby JM, Richards HS, Cousins S, Wallis L, Clarke A, Metcalfe S, Frost W, Waters S, Shah S, Grover J, Byrne J, Ward D, Dacombe R, Wickham L, Gardiner MD, Bal B, Steel C, Pywell S, Etemadi M, Ives J, Huxtable R, Avery KNL, Rooshenas L, Elliott D.   +23 more
europepmc   +1 more source

Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry [PDF]

Daron Acemoglu, Joshua Linn
core  

Validation of a Genetic Risk Score Combined With Clinical Variables for Predicting Pulmonary Fibrosis in Early Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). This study aimed to externally validate a genetic risk score (GRS) and a combined risk score (CRS) for predicting the risk of RA‐associated PF in an independent cohort of patients with early RA.
Mikael Brink, Austin Wheeler, Bryant R. England, Solbritt Rantapää‐Dahlqvist   +3 more
wiley   +1 more source

Harnessing AI for Transformative Healthcare: Proceedings and Strategic Roadmap from AI4Health Industry Day 2026 in Delaware. [PDF]

Dela J Public Health
Payen C, Peng X, Shi W, Callahan P.
europepmc   +1 more source

Performance Characteristics of Anti–Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti–collagen II (Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick, Marcela A. Ferrada, Alice Fike, Kaitlin A. Quinn, Benjamin A. Turturice, Casey Stein, Peter C Grayson   +6 more
wiley   +1 more source

A Strategic Partnership to Advance AI Applications in Genomics and Bioinformatics for Health Innovation. [PDF]

JMIR Bioinform Biotechnol
Tan AC, Gamsiz Uzun ED.
europepmc   +1 more source